Factores de riesgo de enfermedad residual en la re-RTU en una gran cohorte de pacientes con enfermedad T1G3

Pisano, F; Gontero, P; Joniau, S; Serretta, V; Larré, S; Di Stasi, S; Grotenhuis, A; Colombo, R; Dalbagni, G; Bartoletti, R.
Actas urol. esp ; 45(6): 473-478, julio-agosto 2021. tab
Artículo en Español | IBECS (España) | ID: ibc-217001

Documentos relacionados

  1. Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients.
  2. Aggressive Angiomyxoma of the Pelvis: 35-Year Experience.
  3. The Negative Prognostic Impact of Lymph Node Skip Metastasis in Stage III Colon Cancer With pN1 Disease: A Single-Center and Retrospective Cohort Study.
  4. Is High-Grade Tumor Budding an Independent Prognostic Factor in Stage II Colon Cancer?
  5. Seguridad de abatacept en pacientes con artritis reumatoidea
  6. Cancer neuroscience: State of the field, emerging directions.
  7. Feasibility, Indications, and Prognostic Significance of Selective Lateral Pelvic Lymph Node Dissection After Preoperative Chemoradiotherapy in Middle/Low Rectal Cancer: Results of a Multicenter Lateral Node Study in China.
  8. Does Completeness of the Mesorectal Excision Still Correlate With Local Recurrence?
  9. Coordinated cancer chaos.
  10. Oncological Outcomes of Transanal Endoscopic Surgery for the Surgical Management of T2 and T3 Rectal Cancer.